Page last updated: 2024-09-03

efaproxiral and Cancer of Lung

efaproxiral has been researched along with Cancer of Lung in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayoub, J; Boyd, AP; Cagnoni, PJ; Choy, H; Curran, WJ; Hamburg, S; Kleinberg, L; Kreisman, H; Nabid, A; Roa, W; Scott, C; Smith, C; Souhami, L; Spanos, W; Stea, B	1
Boyd, AP; Cagnoni, PJ; Chang, EL; Fortin, A; Kresl, JJ; Mercier, JP; Nabid, A; Senzer, N; Shaw, E; Stea, B; Suh, JH	1
Cannell, E	1
Amorino, GP; Choy, H; Hercules, SK; Holburn, GE; Lee, H; Paschal, CB; Shyr, Y; Steffen, RP	1

Trials

2 trial(s) available for efaproxiral and Cancer of Lung

Article	Year
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-01, Volume: 23, Issue:25 Topics: Adult; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Propionates; Radiation-Sensitizing Agents; Survival Analysis	2005
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jan-01, Volume: 24, Issue:1 Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents	2006

Article

Year

Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-01, Volume: 23, Issue:25

Topics: Adult; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Propionates; Radiation-Sensitizing Agents; Survival Analysis

2005

Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jan-01, Volume: 24, Issue:1

Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents

2006

Other Studies

2 other study(ies) available for efaproxiral and Cancer of Lung

Article	Year
New hope for old drug in patients with brain metastases. The Lancet. Oncology, 2006, Volume: 7, Issue:2 Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Propionates; Radiation-Sensitizing Agents	2006
Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13. Radiation research, 2001, Volume: 156, Issue:3 Topics: Allosteric Regulation; Aniline Compounds; Animals; Carcinoma, Large Cell; Hemoglobins; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Transplantation; Oxygen; Propionates; Radiation-Sensitizing Agents; Tumor Cells, Cultured	2001

Article

Year

New hope for old drug in patients with brain metastases.

The Lancet. Oncology, 2006, Volume: 7, Issue:2

Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Propionates; Radiation-Sensitizing Agents

2006

Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.

Radiation research, 2001, Volume: 156, Issue:3

Topics: Allosteric Regulation; Aniline Compounds; Animals; Carcinoma, Large Cell; Hemoglobins; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Transplantation; Oxygen; Propionates; Radiation-Sensitizing Agents; Tumor Cells, Cultured

2001